SEARCH

SEARCH BY CITATION

References

  • 1
    Gonzalez-Buritica H, Khamashta MA, Hughes GR: Synovial fluid phospholipase A2s and inflammation. Ann Rheum Dis 48: 267270, 1989
  • 2
    Pruzanski W, Vadas P: Phospholipase A2: a mediator between proximal and distal effectors of inflammation. Immunol Today 12: 143146, 1991
  • 3
    Dennis EA, Rhee SG, Billah MM, Hannun YA: Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 5: 20682077, 1991
  • 4
    Chang J, Musser JH, McGregor H: Phospholipase A2: function and pharmacologic regulation. Biochem Pharmacol 36: 24292436, 1987
  • 5
    Dennis EA: Regulation of eicosanoid production: role of phospholipase and inhibitors. Biotechnology 5: 12941300, 1987
  • 6
    Dennis EA: Phospholipases, The Enzymes. Vol. 16. New York, Academic Press, 1983
  • 7
    Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231: 232235, 1971
  • 8
    Smith JB, Willis AL: Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol 231: 235237, 1971
  • 9
    Flower RJ, Blackwell GJ: The importance of phospholipase A2 in prostaglandin biosynthesis. Biochem Pharmacol 25: 285291, 1976
  • 10
    Samuelson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science 237: 11711175, 1987
  • 11
    Robinson DR, McGuire MB, Levin L: Prostaglandins in the rheumatic diseases. Ann N Y Acad Sci 256: 318329, 1974
  • 12
    Van der Wiele FC, Atsma W, Roelofson B, van Linde M, van Binsbergen J, Radvanyi R, Raykova D, Slotboom AJ, de Haas GH: Site-specific-NH2 monoacylation of pancreatic phospholipase A2. 2. Transformation of soluble phospholipase A2 into a highly penetrating “membrane bound” form. Biochemistry 27: 16881694, 1988
  • 13
    Cho WA, Tomasselli AG, Heinrikson RL, Kezdy FJ: The chemical basis for interfacial activation of monomeric phospholipase A2: autocatalytic derivation of the enzyme by acyl transfer from substrate. J Biol Chem 263: 1123711241, 1988
  • 14
    Vadas P, Pruzanski W: Role of extracellular phospholipase A2 in inflammation. Adv Inflamm Res 7: 5259, 1984
  • 15
    Lai CY, Wada K: Phospholipase A2 from human synovial fluid: purification and structural homology to the placental enzyme. Biochem Biophys Res Commun 157: 488493, 1988
  • 16
    Hara S, Hudo I, Chang HW, Matsusta K, Miyamoto T, Inoue K: Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis. J Biochem (Tokyo) 105: 395399, 1989
  • 17
    Bomalaski JS, Lawton P, Browning JL: Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol 146: 39043910, 1991
  • 18
    Recklies AD, White C: Phospholipase A2 is a major component of the salt-extractable pool of matrix proteins in adult human articular cartilage. Arthritis Rheum 34: 11061115, 1991
  • 19
    Seilhamer JJ, Plant S, Pruzanski W, Schilling J, Stefanski E, Vadas P, Johnson LK: Multiple forms of phospholipase A2 in arthritic synovial fluid. J Biochem (Tokyo) 106: 3842, 1989
  • 20
    Kramer RM, Hession C, Johansen B, Hayes G, McGray E, Chow P, Tizard R, Pepinsky RB: Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 264: 57685775, 1989
  • 21
    Levin W, Daniel RF, Stoner CR, Stoller TJ, Wardwell-swanson JA, Angelillo YM, Familletti PC, Crowl RM: Purification of recombinant human secretory phospholipase A2 (Group II) produced in long-term immobilized cell culture. Protein Express Purification 3: 2735, 1992
  • 22
    Hayakawa M, Kudo I, Tomita M, Nojima S: The primary structure of rat platelet phospholipase A2. J Biochem (Tokyo) 104: 767772, 1988
  • 23
    Ono T, Tojo H, Kuramitsu S, Kagamiyama H, Okamoto M: Purification and characterization of a membrane-associated phospholipase A2 from rat spleen. J Biol Chem 263: 57325738, 1988
  • 24
    Ishizaki J, Ohara O, Nakamura E, Tamaki M, Ono T, Kanda A, Yoshida N, Teraoka H, Tojo H, Okamoto M: cDNA cloning and sequence determination of rat membrane-associated phospholipase A2. Biochem Biophys Res Commun 162: 10301036, 1989
  • 25
    Murakami M, Kudo I, Inoue K: In vivo release and clearance of rat platelet phospholipase A2. Biochim Biophys Acta 1005: 270276, 1989
  • 26
    Cabre F, Garcia AM, Carabaza A, Mauleon D, Carganico G: Differential hydrolysis of 1-Alkyl-2-Acyl and diacylglycerophosphocholines by human and non-human phospholipase A2. Biochim Biophys Acta 1124: 297299, 1992
  • 27
    Seilhamer JJ, Randall TL, Yamanaka M, Johnson LK: Novel gene exon homologous to pancreatic phospholipase A2: sequence and chromosomal mapping of both human genes. J Cell Biochem 39: 327337, 1989
  • 28
    Davidson FF, Dennis EA: Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J Mol Evol 31: 228238, 1990
  • 29
    Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL: A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 10431051, 1991
  • 30
    Kramer RM, Roberts EF, Manetta J, Purnam JE: The Ca2+ -sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 266: 52685272, 1991
  • 31
    Ghomashchi F, Schuttel S, Jain MK, Gelb MH: Kinetic analysis of a high molecular weight phospholipase A2 from rat kidney: divalent metal-dependent trapping of enzyme on product-containing vesicles. Biochemistry 31: 38143824, 1992
  • 32
    Portilla D, Mandel LJ, Barsagi D, Millington DS: Anoxia induces phospholipase A2 activation in rabbit renal proximal tubules. Am J Physiol 262: F354F360, 1992
  • 33
    Bomalaski JS, Clark MA, Douglas SD, Zurier RB: Enhanced phospholipase A2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Leukoc Biol 38: 649654, 1985
  • 34
    Bomalaski JS, Clark MA, Zurier RB: Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis Rheum 29: 312318, 1986
  • 35
    Seitz M, Deimann W, Gram N, Hunstein W, Gemsa D: Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol 25: 405416, 1982
  • 36
    Pruzanski W, Bogoch E, Wloch M, Vadas P: The role of phospholipase A2 in the pathophysiology of osteoarthritis. J Rheumatol Suppl 27: 117119, 1991
  • 37
    Pruzanski W, Vadas P, Fornasier V: Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. J Invest Dermatol 86: 380383, 1986
  • 38
    Vadas P, Pruzanski W, Kim J, Fornasier V: The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Am J Pathol 134: 807811, 1989
  • 39
    Harris ED Jr: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322: 12771289, 1990
  • 40
    Gramzow M, Fritsche U, Robitzki A, Friese K, Muller WEG: Role of phospholipase A2 in the stimulation of sponge cell proliferation by homologous lectin. Cell 59: 939948, 1989
  • 41
    Arita H, Hanasaki K, Nakano T, Oka S, Teraoka H, Matsumoto K: Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J Biol Chem 266: 1913919141, 1991
  • 42
    Bomalaski JS, Steiner MR, Simon PL, Clark MA: IL-1 increases phospholipase A2 activity, expression of phospholipase A2-activating protein, and release of linoleic acid from the murine T helper cell line El-4. J Immunol 148: 155160, 1992
  • 43
    Ogawa M, Yamashita S, Sakamoto K, Ikei S: Elevation of serum group II phospholipase A2 in patients with cancers of digestive organs. Res Commun Chem Pathol Pharmacol 74: 241244, 1991
  • 44
    Mutch DG, Powell CB, Kao MS, Collins JL: Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha. Cancer Res 52: 855872, 1992
  • 45
    Sharma SV: Melittin resistance: a counterselection for ras transformation. Oncogene 7: 193201, 1992
  • 46
    Glasgow WC, Afshari CA, Barrett JC, Eling TE: Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts: differential effects in tumor suppressor gene (+) and (-) phenotypes. J Biol Chem 267: 1077110779, 1992
  • 47
    Rotman EI, Brostrom MA, Brostrom CO: Inhibition of protein synthesis in intact mammalian cells by arachidonic acid. J Biochem (Tokyo) 282: 487494, 1992
  • 48
    Kohn EC, Sandeen MA, Liotta LA: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate and inositol phosphates. Cancer Res 52: 32083212, 1992
  • 49
    Peppelenbosch MP, Tertoolen LGJ, Denhertog J, Delaat SW: Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene-C4 production. Cell 69: 295303, 1992
  • 50
    Lyons-Giordano B, Davis GL, Galbraith W, Pratta MA, Arner EC: Interleukin-1 stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytes. Biochem Biophys Res Commun 164: 488495, 1989
  • 51
    Nakano T, Ohara O, Teraoka H, Arita H: Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 265: 1274512748, 1990
  • 52
    Oka S, Arita H: Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. J Biol Chem 15: 99569960, 1991
  • 53
    Muhl H, Geiger T, Pignat W, Marki F, Vandenbosch H, Cerletti N, Cox D, McMaster G, Vosbeck K, Pfeilschifter J: Transforming growth factors type-beta and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin-1 and forskolin in rat mesangial cells. FEBS Lett 301: 190194, 1992
  • 54
    Schalkwijk C, Pfeilschifter J, Marki F, Vandenbosch H: Interleukin-1 beta-induced and forskolin-induced synthesis and secretion of group-II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2. J Biol Chem 267: 88468851, 1992
  • 55
    Nakano T, Arita H: Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett 273: 2326, 1990
  • 56
    Hulkower KI, Hope WC, Ting C, Anderson CM, Coffee JW, Morgan DW: Interleukin-1 beta stimulates cytosolic phospholipase A2 in rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 184: 712718, 1992
  • 57
    Gilman S: Activation of rabbit articular chondrocytes by recombinant human cytokines. J Rheumatol 14: 10021007, 1987
  • 58
    Suffys P, van Roy F, Fiers W: Tumor necrosis factor and interleukin I activate phospholipase in rat chondrocytes. FEBS Lett 232: 2428, 1988
  • 59
    Stevens TM, Chin JE, McGowan M, Giannaras J, Kerr JS: Phospholipase A2 activity in rabbit chondrocytes. Agents Actions 27: 385387, 1989
  • 60
    Candela M, Barker SC, Ballou LR: Sphingosine synergistically stimulates tumor necrosis factor alpha-induced prostaglandin E2 production in human fibroblasts. J Exp Med 174: 13631369, 1991
  • 61
    Gilman S, Chang J: Characterization of interleukin I induced rabbit chondrocyte phospholipase A2. J Rheumatol 17: 13921396, 1990
  • 62
    Vadas P, Pruzanski W, Stefanski E, Ellies LG, Aubin JE, Sos A, Melcher A: Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. Immunol Lett 28: 187194, 1991
  • 63
    Lipsky PE, Davis LS, Cush JJ, Oppenheimer-Marks N: The role of cytokines in the pathogenesis of rheumatoid arthritis. Semin Immunopathol 11: 123162, 1989
  • 64
    Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305315, 1990
  • 65
    Hirata F, del Carmine R, Nelson CA, Axelrod J, Schiffman E, Warabi A, de Blas A, Nirenberg M, Magnaniello V, Vaughn M, Kumagi S, Green I, Decker JL, Steinberg AD: Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci U S A 78: 31903194, 1981
  • 66
    Touqui T, Rothhut B, Shaw AM, Fradin A, Vargaftig BB, Russo-Marie F: Platelet activation: a role for 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 321: 177180, 1986
  • 67
    Goulding NJ, Podgorski MR, Hale ND, Flower RJ, Browning JL, Pepinsky RB, Maddison PJ: Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 48: 843850, 1989
  • 68
    Rivers JK, Podgorski MR, Goulding NJ, Wong E, McGrath JA, Flower RJ, Greaves MW: The presence of autoantibody to recombinant lipocortin-1 in patients with psoriasis and psoriatic arthritis. Br J Dermatol 123: 569572, 1990
  • 69
    Davidson FF, Dennis EA, Powell M, Glenney JR Jr: Inhibition of PLA2 by lipocortins and calpactins: an effect of binding to substrate phospholipids. J Biol Chem 262: 16981702, 1987
  • 70
    Cirino G, Peers SH, Flower RJ, Browning JL, Pepinsky RB: Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A 86: 34283432, 1989
  • 71
    Cartwright PH, Ilderton E, Sowden JM, Yardley HJ: Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant lipocortin I. Br J Dermatol 121: 155160, 1989
  • 72
    Davidson J, Flower RJ, Milton AS, Peers SH, Rotando D: Antipyretic actions of human recombinant lipocortin-1. Br J Pharmacol 102: 79, 1991
  • 73
    Satoh T, Cohen HT, Katz AI: Intracellular signaling in the regulation of renal Na-K-ATPase. 1. Role of cyclic AMP and phospholipase-A2. J Clin Invest 89: 14961500, 1992
  • 74
    Schalkwijk C, Vervoordeldonk M, Pfeilschifter J, Marki F, Vandenbosch H: Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun 180: 4652, 1991
  • 75
    Haberman E: Bee and wasp venoms. Science 117: 314322, 1972
  • 76
    Clark MA, Chen MJ, Crooke ST, Bomalaski JS: Tumor necrosis factor (cachectin) induces phospholipase A2 activity and the synthesis of a phospholipase A2 activating protein (PLAP) in endothelial cells. Biochem J 250: 125132, 1988
  • 77
    Bomalaski J, Baker DG, Brophy L, Resurreccion NV, Spilberg I, Munian M, Clark MA: A phospholipase A2 activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide and eicosanoids. J Immunol 142: 39573962, 1989
  • 78
    Clark MA, Ozgur LE, Conway TM, Dispoto J, Crooke ST, Bomalaski JS: Cloning of a phospholipase A2-activating protein. Proc Natl Acad Sci U S A 88: 54185422, 1991
  • 79
    Bomalaski J, Fallon M, Turner RA, Crooke ST, Meunier PC, Clark MA: Identification and isolation of the phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. J Lab Clin Med 116: 814825, 1990
  • 80
    Bomalaski JS, Baker DG, Brophy LM, Clark MA: Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2 activating protein. J Immunol 145: 33913397, 1990
  • 81
    Suwa Y, Kudo I, Imaizumi A, Okada M, Kamimura T, Suzuki Y, Chang HW, Hara S, Inoue K: Proteinaceous inhibitor of phospholipase A2 purified from inflammatory sites in rats. Proc Natl Acad Sci U S A 87: 23952399, 1990
  • 82
    Facchiano A, Cordella-Miele E, Miele L, Mukherjee AB: Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action. Life Sci 48: 453464, 1991
  • 83
    Tanaka K, Itazaki H, Toshida Y: Cinatrins: a novel family of phospholipase A2 inhibitors. 2. Biological activities. J Antibiot (Tokyo) 45: 5055, 1992
  • 84
    Marshall LA, Bolognese B, Yuan W, Gelb M: Phosphonate-phospholipid analogues inhibit human phospholipase A2. Agents Actions 34: 106109, 1991
  • 85
    Jain MK, Tao W, Rogers J, Arenson C, Eibl H, Yu BZ: Active-site-directed specific competitive inhibitors of phospholipase A2: novel transition-state analogues. Biochemistry 30: 1025610268, 1991
  • 86
    Jacobson PB, Marshall CA, Sung A, Jacobs RS: Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide. Biochem Pharmacol 39: 15571564, 1990
  • 87
    Hanasaki K, Arita H: Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. J Biol Chem 267: 64146420, 1992
  • 88
    Kanemasa T, Hanasaki K, Arita H: Migration of vascular smooth muscle cells by phospholipase A2 via specific binding sites. Biochim Biophys Acta 1125: 210214, 1992
  • 89
    Dupureur CM, Li Y, Tsai MD: Phospholipase A2 engineering. 6. Single amino acid substitutions of active site residues convert the rigid enzyme to highly flexible conformational states. J Am Chem Soc 114: 27482749, 1992
  • 90
    Ripka WC, Sipio WJ, Galbraith WG: Molecular modeling in the design of phospholipase A2 inhibitors. J Cell Biochem 40: 279286, 1989
  • 91
    Bell JD, Biltonen RL: Molecular details of the activation of soluble phospholipase A2 on lipid bilayers: comparison of computer simulations with experimental results. J Biol Chem 267: 1104611056, 1992